Patient expectations of benefit from systemic treatments for metastatic prostate cancer

Autor: Laura B. Oswald, Rachel Kasimer, Katherine Rappazzo, Angela J. Fought, David F. Penson, Alicia K. Morgans
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Cancer Medicine, Vol 9, Iss 3, Pp 980-987 (2020)
Druh dokumentu: article
ISSN: 2045-7634
DOI: 10.1002/cam4.2783
Popis: Abstract Background Metastatic prostate cancer is incurable, but systemic therapies can improve quality of life and prolong survival. Accurate perceptions of treatment risks and benefits are vital as patients with metastatic disease make treatment decisions. We assessed treatment‐related expectations for benefit among patients with metastatic prostate cancer and explored associated sociodemographic characteristics. Methods Men with metastatic prostate cancer (N = 100) completed surveys assessing their treatment‐related expectations for cancer cure, symptom relief, and prolonged life expectancy. Frequencies were used to describe the proportions of reported expectations. Fisher's exact tests were used to assess the associations of sociodemographic characteristics with treatment expectations. Results One third (33%) of participants believed treatment was at least a little likely to cure their metastatic cancer. Most participants believed treatment could provide symptom relief (76%) and extend life expectancy (95%). Among participants reporting that cancer cure was at least a little likely vs not at all, more men identified as non‐white (24% vs 5%; P = .01), self‐reported good health (90% vs 58%; P
Databáze: Directory of Open Access Journals
Nepřihlášeným uživatelům se plný text nezobrazuje